AU2012223023B2 - Diethylstilbestrol dosage form and use for the treatment of prostate or breast cancer - Google Patents

Diethylstilbestrol dosage form and use for the treatment of prostate or breast cancer Download PDF

Info

Publication number
AU2012223023B2
AU2012223023B2 AU2012223023A AU2012223023A AU2012223023B2 AU 2012223023 B2 AU2012223023 B2 AU 2012223023B2 AU 2012223023 A AU2012223023 A AU 2012223023A AU 2012223023 A AU2012223023 A AU 2012223023A AU 2012223023 B2 AU2012223023 B2 AU 2012223023B2
Authority
AU
Australia
Prior art keywords
pharmaceutical composition
weight
matrix
diethylstilbestrol
sucrose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2012223023A
Other languages
English (en)
Other versions
AU2012223023A1 (en
Inventor
Roland A. AKO
Diana Shu-Lian Chow
Chun Kwong Chu
Je Phil Ryoo
Zheng Wang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nal Pharmaceutical Group Ltd
Original Assignee
Nal Pharmaceutical Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nal Pharmaceutical Group Ltd filed Critical Nal Pharmaceutical Group Ltd
Publication of AU2012223023A1 publication Critical patent/AU2012223023A1/en
Assigned to NAL PHARMACEUTICAL GROUP LIMITED reassignment NAL PHARMACEUTICAL GROUP LIMITED Request for Assignment Assignors: NAL PHARMACEUTICALS LTD.
Application granted granted Critical
Publication of AU2012223023B2 publication Critical patent/AU2012223023B2/en
Priority to AU2017203009A priority Critical patent/AU2017203009B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2012223023A 2011-03-03 2012-03-02 Diethylstilbestrol dosage form and use for the treatment of prostate or breast cancer Ceased AU2012223023B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2017203009A AU2017203009B2 (en) 2011-03-03 2017-05-05 Diethylstilbestrol dosage form and use for the treatment of prostate or breast cancer

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13/040,143 2011-03-03
US13/040,143 US8900634B2 (en) 2008-11-03 2011-03-03 Diethylstilbestrol dosage form and methods of treatment using thereof
PCT/GB2012/050475 WO2012117257A1 (en) 2011-03-03 2012-03-02 Diethylstilbestrol dosage form and use for the treatment of prostate or breast cancer

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2017203009A Division AU2017203009B2 (en) 2011-03-03 2017-05-05 Diethylstilbestrol dosage form and use for the treatment of prostate or breast cancer

Publications (2)

Publication Number Publication Date
AU2012223023A1 AU2012223023A1 (en) 2013-09-19
AU2012223023B2 true AU2012223023B2 (en) 2017-03-16

Family

ID=45841525

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2012223023A Ceased AU2012223023B2 (en) 2011-03-03 2012-03-02 Diethylstilbestrol dosage form and use for the treatment of prostate or breast cancer
AU2017203009A Ceased AU2017203009B2 (en) 2011-03-03 2017-05-05 Diethylstilbestrol dosage form and use for the treatment of prostate or breast cancer

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2017203009A Ceased AU2017203009B2 (en) 2011-03-03 2017-05-05 Diethylstilbestrol dosage form and use for the treatment of prostate or breast cancer

Country Status (13)

Country Link
US (1) US8900634B2 (enExample)
EP (1) EP2680813B1 (enExample)
JP (2) JP6059153B2 (enExample)
KR (1) KR101865776B1 (enExample)
CN (1) CN103561720A (enExample)
AU (2) AU2012223023B2 (enExample)
BR (1) BR112013022438A2 (enExample)
CA (1) CA2827892C (enExample)
ES (1) ES2733282T3 (enExample)
RU (1) RU2602296C2 (enExample)
SG (1) SG192845A1 (enExample)
TW (1) TWI548426B (enExample)
WO (1) WO2012117257A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8715715B2 (en) * 2008-11-03 2014-05-06 Nal Pharmaceuticals Ltd. Dosage form for insertion into the mouth
US8900634B2 (en) * 2008-11-03 2014-12-02 Nal Pharmaceuticals, Ltd. Diethylstilbestrol dosage form and methods of treatment using thereof
MX2015004759A (es) * 2012-10-15 2015-10-12 Chamaeleo Pharma Bvba Fosfestrol para uso en el tratamiento curativo o paliativo de cancer en mamiferos hembras.
EP2906206A1 (en) 2012-10-15 2015-08-19 CHAMAELEO Pharma Bvba Sulfestrol for treating cancer
CA2888161A1 (en) 2012-10-15 2014-04-24 Chamaeleo Pharma Bvba Fosfestrol for use in curative or palliative treatment of prostate cancer
SG11201610358XA (en) 2014-06-24 2017-01-27 Catherine Lee Fast acting orally disintegrating film
CN105997857A (zh) * 2016-06-29 2016-10-12 冯志清 一种用于治疗猪乳房炎的注射液
WO2018091473A1 (en) 2016-11-15 2018-05-24 Klaria Pharma Holding Ab Pharmaceutical formulation
GB201709141D0 (en) 2017-06-08 2017-07-26 Klaria Pharma Holding Ab Pharmaceutical formulation
KR101940401B1 (ko) * 2017-06-12 2019-01-21 경상대학교산학협력단 맛이 차폐된 구강붕해필름 및 이의 제조방법
WO2019028457A2 (en) * 2017-08-04 2019-02-07 University Of Houston System FORMULATION OF NANOSUSPENSION OF DIETHYLSTILBESTROL INJECTABLE
GB201808462D0 (en) 2018-05-23 2018-07-11 Klaria Pharma Holding Ab Pharmaceutical formulation
WO2020030991A1 (en) * 2018-08-09 2020-02-13 Nal Pharmaceutical Group Limited Dosage form for insertion into the mouth
CN113133983B (zh) * 2020-01-20 2023-12-12 鲁南制药集团股份有限公司 一种治疗前列腺癌的药物组合物

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020015730A1 (en) * 2000-03-09 2002-02-07 Torsten Hoffmann Pharmaceutical formulations and method for making
WO2009029543A1 (en) * 2007-08-24 2009-03-05 Aegis Therapeutics, Llc Controlled release formulations
US20100112050A1 (en) * 2008-11-03 2010-05-06 Je Phil Ryoo Dosage Form For Insertion Into The Mouth

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5026560A (en) 1987-01-29 1991-06-25 Takeda Chemical Industries, Ltd. Spherical granules having core and their production
US5464632C1 (en) 1991-07-22 2001-02-20 Prographarm Lab Rapidly disintegratable multiparticular tablet
KR100554924B1 (ko) 1998-05-18 2006-03-03 다케다 야쿠힌 고교 가부시키가이샤 구강내 붕괴 정제
US20030180352A1 (en) * 1999-11-23 2003-09-25 Patel Mahesh V. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US20030147936A1 (en) 2002-02-07 2003-08-07 Velayudhan Sahadevan Prostatic hormonal implants treatment of prostate cancer
PE20060003A1 (es) * 2004-03-12 2006-03-01 Smithkline Beecham Plc Formulacion farmaceutica polimerica para moldear por inyeccion
IL175338A0 (en) * 2006-05-01 2006-09-05 Biota Ltd Orally administrable films and preparation thereof
WO2008045461A2 (en) * 2006-10-11 2008-04-17 Oregon Health & Science University Transdermal diethylstilbestrol for treating prostate cancer
AU2008237246B2 (en) * 2007-04-05 2014-06-05 University Of Kansas Rapidly dissolving pharmaceutical compositions comprising pullulan
US8900634B2 (en) * 2008-11-03 2014-12-02 Nal Pharmaceuticals, Ltd. Diethylstilbestrol dosage form and methods of treatment using thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020015730A1 (en) * 2000-03-09 2002-02-07 Torsten Hoffmann Pharmaceutical formulations and method for making
WO2009029543A1 (en) * 2007-08-24 2009-03-05 Aegis Therapeutics, Llc Controlled release formulations
US20100112050A1 (en) * 2008-11-03 2010-05-06 Je Phil Ryoo Dosage Form For Insertion Into The Mouth

Also Published As

Publication number Publication date
EP2680813A1 (en) 2014-01-08
JP6059153B2 (ja) 2017-01-11
BR112013022438A2 (pt) 2016-12-06
EP2680813B1 (en) 2019-05-08
CN103561720A (zh) 2014-02-05
SG192845A1 (en) 2013-09-30
RU2602296C2 (ru) 2016-11-20
TW201249484A (en) 2012-12-16
US20110189288A1 (en) 2011-08-04
AU2017203009A1 (en) 2017-05-25
RU2013144383A (ru) 2015-04-10
WO2012117257A8 (en) 2013-09-19
KR20140021587A (ko) 2014-02-20
ES2733282T3 (es) 2019-11-28
WO2012117257A1 (en) 2012-09-07
KR101865776B1 (ko) 2018-06-08
US8900634B2 (en) 2014-12-02
JP2017061465A (ja) 2017-03-30
TWI548426B (zh) 2016-09-11
JP2014506914A (ja) 2014-03-20
CA2827892C (en) 2019-12-03
AU2017203009B2 (en) 2018-07-19
AU2012223023A1 (en) 2013-09-19
CA2827892A1 (en) 2012-09-07

Similar Documents

Publication Publication Date Title
AU2017203009B2 (en) Diethylstilbestrol dosage form and use for the treatment of prostate or breast cancer
US20240122846A1 (en) Pharmaceutical composition comprising an androgen receptor inhibitor
HUE035013T2 (en) Delayed release, oral dosage compositions that contain amorphous cddo-me
EP3419671B1 (en) High bioavailability oromucosal pharmaceutical preparations based on cyclodextrin and sucralose
US9168229B2 (en) Soft gelatin capsules
EP2838510A1 (en) Atomoxetine solution
AU2013346766B2 (en) Effervescent tablet
US20220211661A1 (en) Green tea catechins eutectic system
CN114681432B (zh) 一种丁苯酞组合物及其用途
UA112905C2 (uk) Педіатрична рідка композиція для перорального введення, що містить непадутант
HK1192153A (en) Diethylstilbestrol dosage form and use for the treatment of prostate or breast cancer
JP2020533369A (ja) チモキノン含有組成物の調製法
CN118252797A (zh) 一种布地奈德黏性口服溶液、制备方法及其应用
CN120605262A (zh) 辅酶q10口溶膜

Legal Events

Date Code Title Description
PC1 Assignment before grant (sect. 113)

Owner name: NAL PHARMACEUTICAL GROUP LIMITED

Free format text: FORMER APPLICANT(S): NAL PHARMACEUTICALS LTD.

FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired